Name: Suzhou Abogen Biosciences Co. Ltd. - BioCentury Company Profiles - BCIQ
Creator: Biocentury

signInButton

SIGN IN

Find partnering and investment opportunities, uncover and track competitive threats, dive into a company's financing and deal history, its pipeline and molecular targets of interest, and much more. Please note, you are viewing a free version of BCIQ, BioCentury's advanced business intelligence database for the biopharma industry. Request a trial to unlock the full value of BCIQ.

REQUEST A FREE TRIAL

AcquiredOrMerged

Company profiles have been archived if there have been no financings, deals or product updates in BCIQ in the last five years, or the company is out of business.

If you believe a company has been archived in error, please contact us at 

Company profiles have been archived if there have been no financings, deals or product updates in BCIQ in the last five years, or the company is out of business.\nIf you believe a company has been archived in error, please contact us at \nsupport@biocentury.com\n.

Cat-H(AcquiredorMerged)

Historical deals and financings can be found by searching the organization's name in the BCIQ <DEALS> and <FINANCING> Modules.

Default (Company Type Blank)

CategoryHDefault (Company Type Blank)

NonBioPharma

Biopharma related deals can be found by searching the organization's name in the <DEALS> Module.

Cat-H(NonBioPharma)

Biopharma related deals can be found by searching the organization's name in the <DEALS> Module.\n

Suzhou Abogen Biosciences Co. Ltd.

Accentuate the positive: 2021 bright lights, 2022 high hopes

Dec. 1 Quick Takes: New round pushes Abogen’s venture haul over $1B

Brii, RemeGen, CanSino, I-Mab win top company honors at BayHelix awards

Everest parlays Blanchard’s network into mRNA vaccine

Back to School preview, plus Pfizer eats Trillium: a BioCentury podcast

China’s Abogen advancing mRNA vaccine for COVID-19, pipeline with $700M series C